These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8391044)

  • 1. Persistence of anti-HAV IgM antibodies and relapse of hepatitis type A in childhood.
    de la Rubia L; del Pozo F; Carrasco M; Oria de Rueda O; Cebrero M; Garcia de Frias E
    J Hepatol; 1993 Mar; 17(3):421-2. PubMed ID: 8391044
    [No Abstract]   [Full Text] [Related]  

  • 2. [Apparent simultaneous occurrence of hepatitis A and hepatitis B infections].
    Poyraz O; Gökoğlu M; Oztop Y
    Mikrobiyol Bul; 1992 Oct; 26(4):329-32. PubMed ID: 1331719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune response to hepatitis A virus capsid proteins after infection.
    Wang CH; Tschen SY; Heinricy U; Weber M; Flehmig B
    J Clin Microbiol; 1996 Mar; 34(3):707-13. PubMed ID: 8904442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of IgM against hepatitis A virus using tissue culture derived antigen.
    Chitambar SD; Arankalle VA; Banerjee K
    Indian J Med Res; 1991 Jan; 93():19-21. PubMed ID: 1850714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indigenous anti-hepatitis A virus IgM capture ELISA for the diagnosis of hepatitis A.
    Chitambar SD; Murthy-Grewal S; Bokil M; Arankalle VA; Gore MM; Banerjee K
    Indian J Med Res; 1994 Jun; 99():243-51. PubMed ID: 8088883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [ELISA in the detection of hepatitis A: detection of anti-HAV IgM with F(ab')].
    Xu DZ
    Zhonghua Yi Xue Za Zhi; 1985 Jan; 65(1):34-6. PubMed ID: 2983848
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatitis A, B and C seroprevalence in Pakistan.
    Agboatwalla M; Isomura S; Miyake K; Yamashita T; Morishita T; Akram DS
    Indian J Pediatr; 1994; 61(5):545-9. PubMed ID: 7538098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors and prevalence of antibodies against hepatitis A virus (HAV) in children from day-care centers, in Goiania, Brazil.
    Queiróz DA; Cardoso DD; Martelli CM; Martins RM; Porto SO; Borges AM; Azevedo MS; Daher RR
    Rev Inst Med Trop Sao Paulo; 1995; 37(5):427-33. PubMed ID: 8729753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The persistence of hepatitis A IgM antibody after acute clinical hepatitis A.
    Kao HW; Ashcavai M; Redeker AG
    Hepatology; 1984; 4(5):933-6. PubMed ID: 6090293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of enterically transmitted hepatitis viruses in patients attending a tertiary--care hospital in south India.
    Radhakrishnan S; Raghuraman S; Abraham P; Kurian G; Chandy G; Sridharan G
    Indian J Pathol Microbiol; 2000 Oct; 43(4):433-6. PubMed ID: 11344607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solid-phase antibody capture hemadsorption assay for detection of hepatitis A virus immunoglobulin M antibodies.
    Summers PL; Dubois DR; Cohen WH; Macarthy PO; Binn LN; Sjogren MH; Snitbhan R; Innis BL; Eckels KH
    J Clin Microbiol; 1993 May; 31(5):1299-302. PubMed ID: 8388890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detection of IgM anti-hepatitis A antibodies by immunoenzyme technic. Interpretation of results and comparison of 2 tests (Havab-M EIA and Hepanostika anti-HAV IgM].
    Barin F; Lesage G; Dubois F; Yvonnet B; Coursaget P; Goudeau A
    Pathol Biol (Paris); 1983 Dec; 31(10):825-8. PubMed ID: 6322094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Placebo-controlled efficacy study of hepatitis A vaccine in Valdivia, Chile.
    Riedemann S; Reinhardt G; Frösner GG; Ibarra H; Moraleda L; Hering V; Siegel F; Toledo C; Leon J; Gonzalez JL
    Vaccine; 1992; 10 Suppl 1():S152-5. PubMed ID: 1335650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute viral hepatitis A patient with early negative HAV-IGM antibody.
    Wilairatana P
    Southeast Asian J Trop Med Public Health; 1996 Mar; 27(1):202-3. PubMed ID: 9031430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rapid detection of anti-HAV IgM by solid-phase immunosorbent hemagglutination inhibition test].
    Xian L
    Zhonghua Liu Xing Bing Xue Za Zhi; 1992 Aug; 13(4):229-32. PubMed ID: 1338714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevalence of antibodies against hepatitis A virus (HAV) in a population of Mexican children].
    Ramirez Mayans JA; Cervantes Bustamante R; Jiron Castro R; Oyervides Garcia CI; Mata Rivera N; Navarrete Delgadillo Natividad MA; Sosa Martinez MC
    Acta Gastroenterol Latinoam; 1997; 27(2):99-102. PubMed ID: 9412137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence of hepatitis A virus antibodies in a pediatric population of southern Spain.
    Rodriguez-Iglesias MA; Pérez-Gracia MT; Garcia-Valdivia MS; Pérez-Ramos S
    Infection; 1995; 23(5):309. PubMed ID: 8557393
    [No Abstract]   [Full Text] [Related]  

  • 18. Sex-related differences in immunoglobulin M and in total antibody response to hepatitis A virus observed in two epidemics of hepatitis A.
    Hatzakis A; Hadziyannis S
    Am J Epidemiol; 1984 Dec; 120(6):936-42. PubMed ID: 6095654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients with hepatitis A with negative IgM-HA antibody at early stages.
    Hirata R; Hoshino Y; Sakai H; Marumo F; Sato C
    Am J Gastroenterol; 1995 Jul; 90(7):1168-9. PubMed ID: 7611220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistence of IgM hepatitis A antibody after clinical type A hepatitis.
    Chen DS; Sung JL
    Hepatology; 1985; 5(4):705. PubMed ID: 2991108
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.